Please login to the form below

Not currently logged in
Email:
Password:

VPAS

This page shows the latest VPAS news and features for those working in and with pharma, biotech and healthcare.

Europe responding to gene therapy challenge, but picture remains fragmented

Europe responding to gene therapy challenge, but picture remains fragmented

The new framework will build on the new UK-wide pricing agreement, the Voluntary Scheme for Branded Medicines Pricing and Access ( VPAS), and is expected to go out to industry for

Latest news

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Let's be ambitious for patients and life sciences investment in Global Britain Let's be ambitious for patients and life sciences investment in Global Britain

    Industry argues that the remarkable VPAS deal which caps NHS spending on medicines would cover any costs. ... A new 10-year VPAS with more substantial and defined NICE reform locked in?

  • Hanover Communications Hanover Communications

    Since this Pharmaceutical Industry Competitiveness Task Force report in 2005, there have been at least five UK life science strategies plus three PPRS or VPAS deals.

  • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. ... VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....